Categories Earnings, Health Care

Boston Scientific stock falls as Q1 earnings and sales missed consensus estimates

Boston Scientific (NYSE: BSX) reported first quarter 2019 earnings results before the market opened today. The medical technology company’s earnings and sales figures missed analysts’ views and the stock was down about 4% in the pre-market trading hours.

Boston Scientific posted an adjusted EPS of $0.35 in Q1, short of the expected EPS of $0.36 by the analysts. Sales grew 4.8% year-over-year on a reported basis to $2.49 billion and fell short of the expected $2.54 billion. GAAP earnings of $424 million or $0.30 per share in the recently ended quarter increased from earnings of $298 million or $0.21 per share in the prior-year quarter.

Boston Scientific (BSX) Q1 2019 earnings infograph

For FY19, Boston Scientific lifted its adjusted EPS outlook and lowered sales growth guidance. The company now estimates 2019 GAAP income to be in a range of $1.09 to $1.13 per share compared to prior guidance of $1.13 to $1.18 per share and estimates adjusted earningsto be in the range of $1.54 to $1.58 per share versus the prior guidance of $1.53 to $1.58 per share.

The company now estimates revenue growth for the full-year 2019, versus the prior year period, to be in a range of 7-8% on a reported basis compared to prior guidance of 7-9%.

For Q2, Boston Scientific targets GAAP EPS to be between $0.23 and $0.25 and adjusted EPS to be between $0.37 and $0.39. Revenue is expected to grow 5% to 7% on a reported basis.

“Our global team and differentiated portfolio enabled us to deliver good sales and earnings growth this quarter, despite some revenue softness compared to our estimates,” said CEO Mike Mahoney.

Yesterday, Boston Scientific reported that it has received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge Aortic Valve System, a procedure which will help patients with severe aortic valve disease who are considered at high risk for surgical valve replacement via open heart surgery. The company commenced a controlled launch of the valve system in Europe in March and expects to begin a controlled launch in the US in the coming weeks.

Last week, Boston Scientific’s peer Intuitive Surgical (ISRG) posted its first quarter 2019 results.
The Sunnyvale-based firm reported Q1 earnings of $2.61 per share on an adjusted basis, up 7% year-over-year, but missed Wall Street’s views. Revenue grew 15% annually to $974 million.

BSX stock, which ended in green (+2.75%) yesterday, had gained 25% in the past 12 months and 2% since the beginning of 2019.

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

 

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q3 2024

Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to

Key highlights from Exxon Mobil Corporation’s (XOM) Q3 2024 earnings results

Exxon Mobil Corporation (NYSE: XOM) reported its third quarter 2024 earnings results today. Total revenues and other income remained relatively flat at $90 billion compared to the same period a

AAPL Earnings: Apple Q4 2024 sales rise 6% YoY, beat estimates

Apple Inc. (NASDAQ: AAPL) reported an increase in revenues for the fourth quarter of 2024. The top line came in above estimates. The gadget giant generated revenues of $94.9 billion

Comments

  1. Pingback: Reba Fleurantin
  2. Pingback: Chirurgie Tunisie
  3. Pingback: DENTAL HOSPITAL
  4. Pingback: Academic Advising
  5. Pingback: circular axis
  6. Pingback: MSc in pharmacy
  7. Pingback: Teeth Whitening
  8. Pingback: Pediatrics
  9. Pingback: political action
  10. Pingback: Fiverr Earn
  11. Pingback: Fiverr Earn
  12. Pingback: Fiverr Earn
  13. Pingback: Fiverr Earn
  14. Pingback: Fiverr Earn
  15. Pingback: fiverrearn.com
  16. Pingback: fiverrearn.com
  17. Pingback: fiverrearn.com
  18. Pingback: TMS System
  19. Pingback: flatbed broker
  20. Pingback: clima para hoy
  21. Pingback: fiverrearn.com
  22. Pingback: fiverrearn.com
  23. Pingback: bitcoin
  24. Pingback: swimsuit for women
  25. Pingback: sorority jewelry
  26. Pingback: future university
  27. Pingback: multisbobet
  28. Pingback: bulldogs puppy
  29. Pingback: Fiverr.Com
  30. Pingback: Fiverr
  31. Pingback: Warranty
  32. Pingback: Grand piano moving
  33. Pingback: Grand piano moving
  34. Pingback: FUE
  35. Pingback: Packing services
  36. Pingback: Classic Books 500
  37. Pingback: FiverrEarn
  38. Pingback: FiverrEarn
  39. Pingback: FiverrEarn
  40. Pingback: FiverrEarn
  41. Pingback: Speaker
  42. Pingback: pupuk organik
  43. Pingback: partners
  44. Pingback: redboost
  45. Pingback: frenchie puppies
  46. Pingback: Betting tips
  47. Pingback: FiverrEarn
  48. Pingback: live sex cams
  49. Pingback: live sex cams
  50. Pingback: FiverrEarn
  51. Pingback: FiverrEarn
  52. Pingback: FiverrEarn
  53. Pingback: FiverrEarn
  54. Pingback: FiverrEarn
  55. Pingback: FiverrEarn
  56. Pingback: FiverrEarn
  57. Pingback: serialebi qaerulad
  58. Pingback: Milking
  59. Pingback: pearl
  60. Pingback: email
  61. Pingback: Slot Thailand
  62. Pingback: Kuliah Termurah
  63. Pingback: FiverrEarn
  64. Pingback: FiverrEarn
  65. Pingback: cheap sex cams
  66. Pingback: live sex cams
  67. Pingback: Freeze dried
  68. Pingback: frt trigger
  69. Pingback: cannabis Ice Kream
  70. Pingback: 늑대닷컴
  71. Pingback: Gamble feature
  72. Pingback: One Peace AMV
  73. Pingback: One Peace AMV
  74. Pingback: allgame
  75. Pingback: 918kiss
  76. Pingback: หวย24
  77. Pingback: Lipstick shades
  78. Pingback: pg slot
  79. Pingback: judi online
  80. Pingback: megagame
  81. Pingback: 25-06 ammo
  82. Pingback: ozempic
  83. Pingback: 44-40 ammo
  84. Pingback: masumintl
  85. Pingback: masumintl
  86. Pingback: ItMe.Xyz
  87. Pingback: ItMe.Xyz
  88. Pingback: Bokeo Thailand
  89. Pingback: Bulk URL Shortener
Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top